Biora Therapeutics, Inc. has entered a research collaboration with a large pharmaceutical company for its BioJet Systemic Oral Delivery Platform. The agreement provides funding to test the platform’s ability to achieve bioavailability through oral delivery of the undisclosed collaborator’s molecules to the small intestine in animal models. The BioJet systemic oral therapeutics platform uses an ingestible capsule for needle-free, oral delivery of large molecules designed to achieve systemic bi...